David Katzoff's most recent trade in Alzamend Neuro Inc was a trade of 5,000 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alzamend Neuro Inc | David J. Katzoff | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 21 Mar 2025 | 5,000 | 5,540 | - | 1.0 | 5,048 | Common Stock |
| Alzamend Neuro Inc | David Katzoff | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 14 Sep 2022 | 10,000 | 28,000 | - | 1.1 | 11,092 | Common Stock |